US Federal Contractor Registration
CE Marked

Hemoglobin A1c

Catalog #: 15-H7546-32


METHOD

Immunoturbidmetric

TECHNICAL INFORMATION

Format: Liquid
Wavelength: 660 nm
Linearity: 2.0-16.0%
Expected Values: <6.0% non diabetic
Storage Temperature: 2-8°C
Reconstituted Stability: Ready to use liquid
Configuration: 1 x 24 mL / 1 x 8 mL
Test/Kit: 160
Disclaimer: Actual test/kit numbers may be lower due to instrument limitation.
  • Description
  • Ordering Information
  • Related Products
  • Documentation
Intended Use
For the quantitative determination of Hemoglobin A1c (HbA1c) in human blood using the Tokyo Boeki Medisys Inc. Biolis 24i analyzer. The determination of HbA1c is most commonly performed for the evaluation of glycemic control in diabetes mellitus. HbA1c values provide an indication of glucose levels over the preceding 4-8 weeks. A higher HbA1c value indicates poorer glycemic control. For in vitro diagnostic use only.
Principle
This method utilizes the interaction of antigen and antibody to directly determine the HbA1c in whole blood. Total hemoglobin and HbA1c have the same unspecific absorption rate to latex particles. When mouse antihuman HbA1c monoclonal antibody is added (R2), latex-HbA1c-mouse anti human HbA1c antibody complex is formed. Agglutination is formed when goat antimouse IgG polyclonal antibody interacts with the monoclonal antibody. The amount of agglutination is proportional to the amount of HbA1c absorbed on to the surface of latex particles. The amount of agglutination is measured as absorbance. The HbA1c value is obtained from a calibration curve.